Global Autotransfusion Systems Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Autotransfusion Systems Market is expected to grow from USD 384.67 Million in 2018 to USD 548.22 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.19%.
The positioning of the Global Autotransfusion Systems Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Autotransfusion Systems Market including are Atrium Medical Corporation, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biom?dica, Fresenius Medical Care AG & Co. KGaA, Gen World Medical Devices, Haemonetics Corporation, Livanova PLC, Medtronic PLC, Redax, SARSTEDT AG & Co. Kg, Teleflex Incorporated, and Zimmer Biomet Holdings Inc..
On the basis of Type, the Global Autotransfusion Systems Market is studied across Autotransfusion Accessories and Autotransfusion Products.
On the basis of Product, the Global Autotransfusion Systems Market is studied across Off Pump Transfusion Devices and On Pump Transfusion Devices.
On the basis of Application, the Global Autotransfusion Systems Market is studied across Cardiac Surgeries, Organ Transplantation, Orthopedic Surgeries, and Trauma Procedures.
On the basis of End User, the Global Autotransfusion Systems Market is studied across Ambulatory Surgical Centers, Emergency Rooms, Hospitals, and Nursing Homes.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Autotransfusion Systems Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Autotransfusion Systems Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Autotransfusion Systems Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Autotransfusion Systems Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Autotransfusion Systems Market
The report answers questions such as:
1. What is the market size of Autotransfusion Systems market in the Global?
2. What are the factors that affect the growth in the Global Autotransfusion Systems Market over the forecast period?
3. What is the competitive position in the Global Autotransfusion Systems Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Autotransfusion Systems Market?
5. What are the opportunities in the Global Autotransfusion Systems Market?
6. What are the modes of entering the Global Autotransfusion Systems Market?
The positioning of the Global Autotransfusion Systems Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Autotransfusion Systems Market including are Atrium Medical Corporation, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biom?dica, Fresenius Medical Care AG & Co. KGaA, Gen World Medical Devices, Haemonetics Corporation, Livanova PLC, Medtronic PLC, Redax, SARSTEDT AG & Co. Kg, Teleflex Incorporated, and Zimmer Biomet Holdings Inc..
On the basis of Type, the Global Autotransfusion Systems Market is studied across Autotransfusion Accessories and Autotransfusion Products.
On the basis of Product, the Global Autotransfusion Systems Market is studied across Off Pump Transfusion Devices and On Pump Transfusion Devices.
On the basis of Application, the Global Autotransfusion Systems Market is studied across Cardiac Surgeries, Organ Transplantation, Orthopedic Surgeries, and Trauma Procedures.
On the basis of End User, the Global Autotransfusion Systems Market is studied across Ambulatory Surgical Centers, Emergency Rooms, Hospitals, and Nursing Homes.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Autotransfusion Systems Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Autotransfusion Systems Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Autotransfusion Systems Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Autotransfusion Systems Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Autotransfusion Systems Market
The report answers questions such as:
1. What is the market size of Autotransfusion Systems market in the Global?
2. What are the factors that affect the growth in the Global Autotransfusion Systems Market over the forecast period?
3. What is the competitive position in the Global Autotransfusion Systems Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Autotransfusion Systems Market?
5. What are the opportunities in the Global Autotransfusion Systems Market?
6. What are the modes of entering the Global Autotransfusion Systems Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Autotransfusion Systems Market
3.2. Opportunities in the Autotransfusion Systems Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing number of transplant procedures
4.2.1.2. Advantages associated with the autotransfusion
4.2.1.3. Limited availability of allogenic/donated blood
4.2.2. Restraints
4.2.2.1. High cost and health risk associated with the autotransfusion systems
4.2.2.2. Limited availability of trained perfusionists and surgical technicians
4.2.3. Opportunities
4.2.3.1. High growth potential in emerging economies
4.2.3.2. Development of Low-Cost Autotransfusion Devices
4.2.4. Challenges
4.2.4.1. Government initiatives to streamline the allogenic/donated blood supply
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Autotransfusion Accessories
5.4. Autotransfusion Products
5.4.1. Dual-Mode Autotransfusion Systems
5.4.2. Intraoperative Autotransfusion Systems
5.4.3. Postoperative Autotransfusion Systems
6. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY PRODUCT
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Off Pump Transfusion Devices
6.4. On Pump Transfusion Devices
7. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Cardiac Surgeries
7.4. Organ Transplantation
7.5. Orthopedic Surgeries
7.6. Trauma Procedures
8. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY END USER
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Ambulatory Surgical Centers
8.4. Emergency Rooms
8.5. Hospitals
8.6. Nursing Homes
9. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY GEOGRAPHY
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. Argentina
9.3.4. Brazil
9.3.5. Canada
9.3.6. Mexico
9.3.7. United States
9.4. Asia-Pacific
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.4.3. Australia
9.4.4. China
9.4.5. India
9.4.6. Japan
9.5. Europe, Middle East & Africa
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.5.3. France
9.5.4. Germany
9.5.5. Italy
9.5.6. Spain
9.5.7. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. 360iResearch FPNV Positioning Matrix for Global Autotransfusion Systems Market
10.2. Market Vendor Ranking Analysis for Global Autotransfusion Systems Market
10.3. Competitive News Feed Analysis for Global Autotransfusion Systems Market
11. COMPANY USABILITY PROFILES
11.1. Atrium Medical Corporation
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Becton, Dickinson and Company
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. Beijing ZKSK Technology Co., Ltd.
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Braile Biom?dica
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Fresenius Medical Care AG & Co. KGaA
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Gen World Medical Devices
11.7. Haemonetics Corporation
11.8. Livanova PLC
11.9. Medtronic PLC
11.10. Redax
11.11. SARSTEDT AG & Co. Kg
11.12. Teleflex Incorporated
11.13. Zimmer Biomet Holdings Inc.
12. APPENDIX
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Autotransfusion Systems Market
3.2. Opportunities in the Autotransfusion Systems Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing number of transplant procedures
4.2.1.2. Advantages associated with the autotransfusion
4.2.1.3. Limited availability of allogenic/donated blood
4.2.2. Restraints
4.2.2.1. High cost and health risk associated with the autotransfusion systems
4.2.2.2. Limited availability of trained perfusionists and surgical technicians
4.2.3. Opportunities
4.2.3.1. High growth potential in emerging economies
4.2.3.2. Development of Low-Cost Autotransfusion Devices
4.2.4. Challenges
4.2.4.1. Government initiatives to streamline the allogenic/donated blood supply
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Autotransfusion Accessories
5.4. Autotransfusion Products
5.4.1. Dual-Mode Autotransfusion Systems
5.4.2. Intraoperative Autotransfusion Systems
5.4.3. Postoperative Autotransfusion Systems
6. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY PRODUCT
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Off Pump Transfusion Devices
6.4. On Pump Transfusion Devices
7. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Cardiac Surgeries
7.4. Organ Transplantation
7.5. Orthopedic Surgeries
7.6. Trauma Procedures
8. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY END USER
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Ambulatory Surgical Centers
8.4. Emergency Rooms
8.5. Hospitals
8.6. Nursing Homes
9. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET, BY GEOGRAPHY
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. Argentina
9.3.4. Brazil
9.3.5. Canada
9.3.6. Mexico
9.3.7. United States
9.4. Asia-Pacific
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.4.3. Australia
9.4.4. China
9.4.5. India
9.4.6. Japan
9.5. Europe, Middle East & Africa
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.5.3. France
9.5.4. Germany
9.5.5. Italy
9.5.6. Spain
9.5.7. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. 360iResearch FPNV Positioning Matrix for Global Autotransfusion Systems Market
10.2. Market Vendor Ranking Analysis for Global Autotransfusion Systems Market
10.3. Competitive News Feed Analysis for Global Autotransfusion Systems Market
11. COMPANY USABILITY PROFILES
11.1. Atrium Medical Corporation
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Becton, Dickinson and Company
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. Beijing ZKSK Technology Co., Ltd.
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Braile Biom?dica
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Fresenius Medical Care AG & Co. KGaA
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Gen World Medical Devices
11.7. Haemonetics Corporation
11.8. Livanova PLC
11.9. Medtronic PLC
11.10. Redax
11.11. SARSTEDT AG & Co. Kg
11.12. Teleflex Incorporated
11.13. Zimmer Biomet Holdings Inc.
12. APPENDIX
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
